By David | Biotech News Today
Gene therapy works by giving cells a working copy of a gene, or by correcting a faulty one, so the body can make the protein it was missing. A delivery vehicle called a vector carries the genetic instructions into the patient’s cells. Once inside, the cell reads those instructions and starts doing the job the damaged gene could not do.
That is the short answer. This guide explains each step in plain language, compares the main delivery methods, and looks at real treatments that are already approved.
What Is Gene Therapy?
Gene therapy is a medical approach that treats or prevents disease by changing genetic material inside a person’s cells. Instead of managing symptoms with a drug every day, the idea is to fix the cause at the DNA level. The U.S. National Human Genome Research Institute describes it as a technique that uses genes to treat, prevent or cure a disease.
It is a branch of modern biotech medicine, and it builds on the basics covered in our Biotechnology 101 guide.
How Gene Therapy Works: Step by Step
The exact process depends on the disease and the product, but most gene therapies follow the same basic path.
Step 1: Find the genetic cause
Doctors first confirm that a disease is caused by a known change in a gene. Genetic testing is used to identify the faulty gene. Gene therapy works best for conditions where one gene is responsible, such as some inherited eye diseases, blood disorders and muscle diseases.
Step 2: Design the therapeutic gene
Scientists prepare a healthy copy of the gene, or a set of instructions for editing the faulty one. This genetic payload is built in a laboratory so that it can be read by human cells.
Step 3: Choose a vector
Genetic material cannot simply be injected and expected to enter the right cells. It needs a carrier. Most carriers are viruses that have been modified so they cannot cause illness. Some newer methods use tiny fat particles instead.
Step 4: Deliver the gene
The vector reaches the patient’s cells in one of two ways: directly inside the body (in vivo) or outside the body (ex vivo). Both are explained in the table below.
Step 5: The cell uses the new instructions
After delivery, the cell reads the new genetic instructions and begins making the missing or corrected protein. In some therapies the new gene stays separate from the patient’s own DNA. In others it is added into the DNA permanently.
Step 6: Follow-up and monitoring
Patients are monitored for months or years afterwards. Doctors check whether the treatment is working, how long the effect lasts, and whether any late side effects appear. Regulators such as the U.S. FDA often expect long-term follow-up for these products.
In Vivo vs. Ex Vivo Gene Therapy
| Feature | In vivo | Ex vivo |
|---|---|---|
| Where the gene is delivered | Directly into the body (blood, eye, muscle, liver) | Into cells taken out of the body |
| What happens | Vector is infused or injected into the patient | Cells are collected, modified in a lab, then returned |
| Typical cells targeted | Retina, liver, muscle, nerve cells | Blood stem cells, T cells |
| Hospital process | Often a single infusion or injection | Cell collection, lab processing, conditioning, infusion |
| Example | Luxturna (inherited retinal disease) | Casgevy (sickle cell disease) |
Common Vectors Used to Deliver Genes
| Vector | Main features | Common use |
|---|---|---|
| AAV (adeno-associated virus) | Small payload, low inflammation, usually stays outside the cell’s DNA | Eye, muscle, liver and nerve diseases |
| Lentivirus | Can add genes into the cell’s DNA, so the change is passed on when cells divide | Ex vivo therapies for blood stem cells and T cells |
| Adenovirus | Carries larger genes but can trigger a stronger immune response | Some research and vaccine uses |
| Lipid nanoparticles | Non-viral fat particles, good for carrying RNA and editing tools | Gene editing and mRNA-based approaches |
Main Approaches Used in Gene Therapy
- Gene replacement: A working copy of the gene is added to make up for a faulty one.
- Gene silencing: A therapy reduces the activity of a gene that is causing harm.
- Gene editing: Tools such as CRISPR cut and change the DNA at a specific spot.
- Adding a new function: Cells are given a new gene so they can do something they normally cannot, as in CAR-T cell therapy for cancer.
Real Examples of Approved Gene Therapies
Luxturna was approved by the FDA in December 2017 for an inherited form of vision loss linked to mutations in the RPE65 gene. It is delivered by injection under the retina using an AAV vector.
Zolgensma was approved in 2019 for spinal muscular atrophy in young children. It is given as a one-time intravenous infusion and delivers a working copy of the SMN1 gene.
Casgevy was approved in late 2023 for sickle cell disease. It is the first approved therapy based on CRISPR gene editing. Doctors collect a patient’s blood stem cells, edit them in the lab, and return them to the patient.
CAR-T cell therapies, such as Kymriah, modify a patient’s own immune cells so they can find and attack certain blood cancers.
Many of these products are part of the wider group of biologics and are often manufactured by specialist partners such as a CDMO.
Risks and Limitations
Gene therapy is promising, but it is not risk-free or suitable for every disease.
- Immune reactions: The body may react to the vector. Some patients cannot be treated because they already have antibodies to it.
- Off-target effects: Gene editing tools can sometimes change DNA in the wrong place.
- Unwanted insertion: In early trials with older viral vectors, DNA was added near genes that control cell growth, and some patients developed leukemia. Newer vectors were designed to lower this risk.
- Liver and other side effects: High doses of some AAV products have been linked to liver problems, so patients are monitored closely.
- Unknown long-term durability: Doctors are still learning how long some treatments last.
Cost and Access
Many approved gene therapies are one-time treatments but carry very high prices, in some cases above $2 million per patient. They are also usually available only at specialist treatment centers, which limits access. Insurers, governments and manufacturers are still working out new payment models.
Frequently Asked Questions
How does gene therapy work in simple words?
It gives cells a correct set of instructions. A carrier delivers a healthy gene, or an editing tool, into the cells, and the cells begin making the protein the body was missing.
Is gene therapy permanent?
It depends on the product. Some therapies are designed to last for years because the changed cells keep working or dividing. Others may fade over time. Long-term studies are still ongoing.
Is gene therapy the same as CRISPR?
No. CRISPR is one tool used in gene editing, which is one type of gene therapy. Other gene therapies simply add a new gene without editing the existing DNA.
How long does the treatment take?
In vivo treatments can be a single infusion or injection. Ex vivo treatments take longer because cells must be collected, modified and prepared before they are returned.
Does gene therapy change the DNA I pass on to my children?
Approved therapies are designed to change body (somatic) cells, not eggs or sperm, so the changes are not meant to be inherited.
Key Takeaways
- Gene therapy treats disease by adding, silencing or editing genes inside cells.
- Vectors, mainly modified viruses or fat particles, carry the genetic instructions.
- Treatment is either in vivo (inside the body) or ex vivo (cells modified in the lab).
- Several therapies are already approved, but cost, safety monitoring and access remain real challenges.
1 Pingback